Filing Flows

Filing Flows › Companies › Angiodynamics › Timeline

Angiodynamics stock timeline

A year of the price with every insider trade, planned sale, earnings report and material 8-K marked

252 sessions0.0% to $11.73

Angiodynamics (ANGO) stock rose 0% over the last 252 sessions, to $11.73. On the way it reported 0 quarters, its insiders filed 3 open-market trades and 2 Form 144 notices of planned sales, and the company filed 2 material 8-Ks. Each is marked on the price and listed with what the stock did next.

ANGO: a year of the stock with every disclosure on itANGO: a year of the stock with every disclosure on it$11.05$12.91$14.78$16.64◆2026-02-03 · Directors and officers: departures, appointments, pay▼2026-07-30 · Nighan Warren JR sold $344K▽2026-07-30 · Form 144: Warren Nighan plans to sell $344K◆2026-10-08 · Material definitive agreement▼2026-10-28 · Trowbridge Stephen A sold $21K▼2026-10-29 · Trowbridge Stephen A sold $290K▽2026-10-29 · Form 144: Stephen Trowbridge plans to sell $290K◆8-K event▼Insider sale▽Planned sale (Form 144)2025-11-062026-11-06
Daily closes, Nov 6, 2025 to Nov 6, 2026; hover a mark for the filing.

Each mark, and what followed

DateKindWhatNext session5 sessions21 sessions
Oct 29, 2026Form 144Form 144: Stephen Trowbridge plans to sell $290K+1.8% (+2.2% vs SPY)+1.0% (+1.7% vs SPY)—
Oct 29, 2026Insider saleTrowbridge Stephen A sold $290K+1.8% (+2.2% vs SPY)+1.0% (+1.7% vs SPY)—
Oct 28, 2026Insider saleTrowbridge Stephen A sold $21K−1.1% (−1.4% vs SPY)−4.4% (−2.4% vs SPY)—
Oct 8, 20268-KMaterial definitive agreement−23.4% (−23.0% vs SPY)−25.0% (−24.0% vs SPY)−18.4% (−12.5% vs SPY)
Jul 30, 2026Form 144Form 144: Warren Nighan plans to sell $344K+0.9% (−0.7% vs SPY)+2.8% (−2.6% vs SPY)+7.6% (+2.0% vs SPY)
Jul 30, 2026Insider saleNighan Warren JR sold $344K+0.9% (−0.7% vs SPY)+2.8% (−2.6% vs SPY)+7.6% (+2.0% vs SPY)
Feb 3, 20268-KDirectors and officers: departures, appointments, pay−1.4% (−0.9% vs SPY)+3.5% (+3.1% vs SPY)+2.1% (+3.4% vs SPY)

Insiders’ record here

In the year on the chart, Angiodynamics' insiders reported 0 open-market buys ($0) and 3 sales ($655K). Of the 1 old enough to score, 1 were followed by the stock doing what the trade implied over the next 63 sessions (beating SPY after a buy, lagging it after a sale); the median excess return after a buy was — and after a sale −22.0%.

Across the whole universe (19,782 scored trades), insider buys beat the market 46% of the time and sales were followed by a lagging stock 61% of the time; buys of $1M or more 39%. Every pattern →

What this kind of 8-K usually did

Item8-KsNext session, medianUp next session21 sessions, medianTypical size
5.02 Directors and officers: departures, appointments, pay39,174−0.1%48%+0.7%±1.4%
1.01 Material definitive agreement23,5250.0%51%+1.0%±1.4%

Across every company in the move-odds universe, measured from the close before the filing. Every 8-K item ranked →

Angiodynamics: every quarter → Live insider trades →

Prices are daily closes; filings and trades are as filed with the SEC (Form 4 within two business days of the trade, 8-K within four of the event). Moves after a mark are the stock's close-to-close change and the same for SPY; they describe the record, not what the next one will do. Not investment advice.